Doctors treated a nine-year-old boy with a rare form of blood cancer called acute promyelocytic leukemia. His specific type involved a genetic change called TTMV::RARA. He also had severe pressure on his spinal cord that needed urgent care. This situation was very unusual and hard to diagnose with standard tests.
The medical team first tried standard treatments with retinoic acid and an arsenic compound. These medicines did not fully clear the cancer from his body. They then added a third drug called venetoclax to the mix. This change helped his body reach a state where the cancer was no longer detectable in his blood.
Scans showed the pressure on his spine went away after the new treatment plan. Seven out of twelve similar cases seen in recent years had this specific genetic change. Often, standard tests miss this rare type of cancer because they look for different genetic markers. Doctors now suggest using new genetic tests to find these hidden cases earlier.
No major side effects were reported during the ten months of follow-up care. However, experts say more studies are needed to confirm these findings. Working together will help doctors find better ways to treat these rare and difficult cases in the future.